Impact of human leukocyte antigen matching on hepatitis B virus recurrence after liver transplantation

Hepatobiliary and Pancreatic Diseases International

Volumn 9, Issue 2, 2010, Pages 139-143

  Zhao, Hong ^a   Hu, Jian Hua ^a   Zhou, Lin ^b   Xu, Xiao ^b   Wu, Jian ^b   Meng, Xue Qin ^b   Fan, Jun ^a   Ma, Wei Hang ^a  

^a ZHEJIANG UNIVERSITY   (China)

^b BEIJING HOSPITAL   (China)

Author keywords

Hepatitis B virus; Human leukocyte antigen; Liver transplantation; Recurrence

Indexed keywords

HEPATITIS B ANTIBODY; LAMIVUDINE; MYCOPHENOLIC ACID; PREDNISONE; TACROLIMUS;

ADOLESCENT; ADULT; AGED; ARTICLE; FEMALE; GRAFT RECIPIENT; HEPATITIS B; HEPATITIS B VIRUS; HLA MATCHING; HLA TYPING; HUMAN; INFECTION PREVENTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; RECURRENT VIRUS INFECTION;

ADOLESCENT; ADULT; AGED; DNA, VIRAL; FEMALE; HEPATITIS B; HISTOCOMPATIBILITY TESTING; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES;

EID: 77951797379     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Futagawa Y, Waki K, Cai J. The association of HLA-DR13 with lower graft survival rates in hepatitis B and primary sclerosing cholangitis Caucasian patients receiving a liver transplant. Liver Transpl 2006;12:600-604.
2. Zheng SS, Chen Y, Liang TB, Lu AW, Wang WL, Shen Y, et al. Prevention of hepatitis B recurrence after liver transplantation using lamivudine or lamivudine combined with hepatitis B Immunoglobulin prophylaxis. Liver Transpl 2006;12:253-258. (Pubitemid 43273784)
3. Vierling JM. Management of HBV infection in liver transplantation patients. Int J Med Sci 2005;2:41-49. (Pubitemid 40944950)
4. Sheldon S, Poulton K. HLA typing and its influence on organ transplantation. Methods Mol Biol 2006;333:157-174.
5. Perz JB, Szydlo R, Sergeant R, Sanz J, O'Shea D, Khan T, et al. Impact of HLA class I and class II DNA high-resolution HLA typing on clinical outcome in adult unrelated stem cell transplantation after in vivo T-cell depletion with alemtuzumab. Transpl Immunol 2007;18:179-185. (Pubitemid 350086952)
6. Jakab SS, Navarro VJ, Colombe BW, Daskalakis C, Herrine SK, Rossi S. Human leukocyte antigen and adult living-donor liver transplantation outcomes: an analysis of the organ procurement and transplantation network database. Liver Transpl 2007;13:1405-1413. (Pubitemid 47629574)
7. Navarro V, Herrine S, Katopes C, Colombe B, Spain CV. The effect of HLA class I (A and B) and class II (DR) compatibility on liver transplantation outcomes: an analysis of the OPTN database. Liver Transpl 2006;12:652-658.
8. Abbott WG, Tsai P, Leung E, Trevarton A, Ofanoa M, Hornell J, et al. Associations between HLA class I alleles and escape mutations in the hepatitis B virus core gene in New Zealandresident Tongans. J Virol 2010;84:621-629.
9. Rehermann B. Intrahepatic T cells in hepatitis B: viral control versus liver cell injury. J Exp Med 2000;191:1263-1268. (Pubitemid 30227115)
10. Neumann UP, Langrehr JM, Naumann U, Lang M, Rayes N, Steinmüller T, et al. Impact of HLA-compatibilities in patients undergoing liver transplantation for HBV-cirrhosis. Clin Transplant 2002;16:122-129. (Pubitemid 34414060)
11. Ramezani A, Hasanjani Roshan MR, Kalantar E, Eslamifar A, Banifazl M, Taeb J, et al. Association of human leukocyte antigen polymorphism with outcomes of hepatitis B virus infection. J Gastroenterol Hepatol 2008;23:1716-1721.
12. Mohamadkhani A, Sotoudeh M, Bowden S, Poustchi H, Jazii FR, Sayehmiri K, et al. Downregulation of HLA class II molecules by G1896A pre-core mutation in chronic hepatitis B virus infection. Viral Immunol 2009;22:295-300.
13. Zheng SS, Xu X, Wu J, Chen J, Wang WL, Zhang M, et al. Liver transplantation for hepatocellular carcinoma: Hangzhou experiences. Transplantation 2008;85:1726-1732.
14. Meng XQ, Zhang X, Fan J, Zhou L, Hao B, Chen XM, et al. Detection of human leukocyte antigen compatibility and antibodies in liver transplantation in China. Hepatobiliary Pancreat Dis Int 2009;8:141-145.
15. Perrillo RP, Mason AL. Hepatitis B and liver transplantation. Problems and promises. N Engl J Med 1993;329:1885-1887.
16. Todo S, Demetris AJ, Van Thiel D, Teperman L, Fung JJ, Starzl TE. Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology 1991;13:619-626.
17. Marzano A, Gaia S, Ghisetti V, Carenzi S, Premoli A, Debernardi-Venon W, et al. Viral load at the time of liver transplantation and risk of hepatitis B virus recurrence. Liver Transpl 2005;11:402-409. (Pubitemid 40533208)
18. Hsu C, Wei SC, Cheng AL, Chen PJ. Strategies to prevent hepatitis B virus reactivation in patients receiving immunosuppressive therapy. Hepatology 2009;50:654-655.
19. Perrillo RP, Wright T, Rakela J, Levy G, Schiff E, Gish R, et al. A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis B. Hepatology 2001;33:424-432. (Pubitemid 32119032)
20. Saab S, Chang AJ, Comulada S, Geevarghese SK, Anselmo RD, Durazo F, et al. Outcomes of hepatitis C- and hepatitis B core antibody-positive grafts in orthotopic liver transplantation. Liver Transpl 2003;9:1053-1061. (Pubitemid 37304461)
21. Hwang S, Moon DB, Lee SG, Park KM, Kim KH, Ahn CS, et al. Safety of anti-hepatitis B core antibody-positive donors for living-donor liver transplantation. Transplantation 2003;75: S45-48. (Pubitemid 36222989)
22. Lo CM, Fan ST, Liu CL, Yong BH, Wong Y, Ng IO, et al. Safety and outcome of hepatitis B core antibody-positive donors in right-lobe living donor liver transplantation. Liver Transpl 2003;9:827-832. (Pubitemid 36974949)
23. Balan V, Ruppert K, Demetris AJ, Ledneva T, Duquesnoy RJ, Detre KM, et al. Long-term outcome of human leukocyte antigen mismatching in liver transplantation: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Hepatology 2008; 48:878-888.
24. Luo Y, Lo CM, Cheung CK, Lau GK, Wong J. Hepatitis B virus-specific CD4 T cell immunity after liver transplantation for chronic hepatitis B. Liver Transpl 2009;15:292-299.
25. Lok AS. Prevention of recurrent hepatitis B post-liver transplantation. Liver Transpl 2002;8:S67-73. (Pubitemid 35154046)
26. Francavilla R, Hadzic N, Underhill J, Heaton N, Rela M, Mieli-Vergani G, et al. Role of HLA compatibility in pediatric liver transplantation. Transplantation 1998;66:53-58. (Pubitemid 28341168)